Literature DB >> 7119078

Pitfalls in the serial assessment of cardiac functional status. How a reduction in "ordinary" activity may reduce the apparent degree of cardiac compromise and give a misleading impression of improvement.

L Goldman, E F Cook, N Mitchell, M Flatley, H Sherman, P F Cohn.   

Abstract

Because the New York Heart Association (NYHA) classification system categorizes patients based on subjective impression of the degree of functional compromise, a reduction in exercise might make a patient seem improved because the new lower level of ordinary activity produced fewer symptoms. To test this hypothesis, we studied three different sets of patients and compared their NYHA classes to their functional classes as determined by a new Specific Activity Scale (SAS) that is based on the metabolic equivalents of oxygen consumption required for activities the patient actually performs. Among ambulatory patients referred for exercise tests, the NYHA class was higher (i.e. indicated the patient was more limited) in 28% of patients and the SAS class was higher in 14% (p less than 0.001). Among patients interviewed at or near the time of catheterization for chest pain, the NYHA was higher in 20% and the SAS class was higher in 20% (p = NS). In both medically and surgically treated patients interviewed 1--3 yr after cardiac catheterization, the NYHA class was higher in only 4%, whereas the SAS class was higher in 28% (p less than 0.001). The SAS class was significantly more likely to be higher in patients who were not working full time and in patients who described their present activity level as sedentary or light. When the NYHA and SAS systems disagreed as to whether a patient was improved, SAS was significantly more likely to correlate with the patient's self-assessment. These findings suggest that some patients restrict their activity as their cardiac disease progresses; the resultant change in the definition of ordinary activity may reduce the apparent degree of cardiac compromise and thus give a false impression of improvement by NYHA criteria.

Entities:  

Mesh:

Year:  1982        PMID: 7119078     DOI: 10.1016/0021-9681(82)90087-x

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  22 in total

1.  Preoperative and long-term cardiac risk assessment. Predictive value of 23 clinical descriptors, 7 multivariate scoring systems, and quantitative dipyridamole imaging in 360 patients.

Authors:  J Lette; D Waters; H Bernier; P Champagne; J Lassonde; M Picard; M Cerino; S Nattel; Y Boucher; F Heyen
Journal:  Ann Surg       Date:  1992-08       Impact factor: 12.969

2.  Assessing patients' improvement in clinical trials.

Authors:  John Spertus
Journal:  BMJ       Date:  2008-05-21

3.  The influence of decisions made by developers on health status questionnaire content.

Authors:  C J O'Leary; P W Jones
Journal:  Qual Life Res       Date:  1998-08       Impact factor: 4.147

4.  Quality of life after myocardial infarction: effect of long term metoprolol on mortality and morbidity.

Authors:  G Olsson; J Lubsen; G A van Es; N Rehnqvist
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-07

5.  Measurement of the quality of life in congestive heart failure-Influence of drug therapy.

Authors:  Christopher J Bulpitt; Astrid E Fletcher
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

Review 6.  Noninvasive tests for diagnosing the presence and extent of coronary artery disease: exercise electrocardiography, thallium scintigraphy, and radionuclide ventriculography.

Authors:  L Goldman; T H Lee
Journal:  J Gen Intern Med       Date:  1986 Jul-Aug       Impact factor: 5.128

7.  Postoperative myocardial infarction and cardiac death. Predictive value of dipyridamole-thallium imaging and five clinical scoring systems based on multifactorial analysis.

Authors:  J Lette; D Waters; J Lassonde; S Dubé; F Heyen; M Picard; M Morin
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

Review 8.  Effect of drug treatment on quality of life in mild to moderate heart failure.

Authors:  D G Waller
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

9.  Psychological distress in primary care patients with heart failure: a longitudinal study.

Authors:  Martin Scherer; Wolfgang Himmel; Beate Stanske; Franziska Scherer; Janka Koschack; Michael M Kochen; Christoph Herrmann-Lingen
Journal:  Br J Gen Pract       Date:  2007-10       Impact factor: 5.386

10.  Psychosocial determinants for frequent primary health care utilisation in patients with heart failure.

Authors:  Martin Scherer; Wolfgang Himmel; Michael M Kochen; Janka Koschack; Dirk Ahrens; Jean-Francois Chenot; Anne Simmenroth-Nayda; Christoph Herrmann-Lingen
Journal:  Psychosoc Med       Date:  2008-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.